Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | MMP8 | P22894 | 1/20 | 0.31 |
| ▸ | MMP13 | P45452 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6655835 | 1.00 | LMNA (0.44) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL503984 | 1.00 | LMNA (0.44) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL954243 | 1.00 | LMNA (0.44) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL1828060 | 1.00 | LMNA (0.44) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL958058 | 1.00 | LMNA (0.44) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL216042 | 1.00 | LMNA (0.44) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL5491848 | 1.00 | LMNA (0.44) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL445081 | 1.00 | LMNA (0.44) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL5492172 | 1.00 | LMNA (0.44) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL143822 | 1.00 | LMNA (0.44) | LMNATHRBCA2CA1MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 651 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2532663-B1 | Naphthalenetetracarboxylic acid derivatives and their use as semiconductors | BASF SE (DE) | 2016-03-16 | — | — | EP | claimed |
| EP-2181172-B1 | HALOGEN-CONTAINING PERYLENETETRACARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF | BASF SE (DE) | 2016-02-24 | — | — | EP | claimed |
| US-9243089-B2 | Copolymer-modified nanoparticles, especially for use in medical articles | BARCIKOWSKI STEPHAN (DE) | 2016-01-26 | — | — | US | claimed |
| US-20140155603-A1 | HALOGEN-CONTAINING PERYLENETETRACARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF | BASF SE (DE) | 2014-06-05 | — | — | US | claimed |
| US-8674104-B2 | Halogen-containing perylenetetracarboxylic acid derivatives and the use thereof | BASF SE (DE) | 2014-03-18 | — | — | US | claimed |
| US-20130123495-A1 | HALOGEN-CONTAINING PERYLENETETRACARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF | CLAP CO., LTD. (KR) | 2013-05-16 | — | — | US | claimed |
| EP-2532663-A1 | Naphthalenecarboxylic acid derivatives and their use as semiconductors | BASF SE (DE) | 2012-12-12 | — | — | EP | claimed |
| US-20090191135-A1 | METHODS FOR THE DISPERSION OF WATER-SOLUABLE OR HYDROPHILIC SUBSTANCES IN A SUPERCRITICALLY PRESSURIZED FLUID | ETHYPHARM CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS | 2009-07-30 | — | — | US | claimed |
| US-7419620-B2 | Dichroic mixtures | ROLIC LTD C/O ROLIC TECHNOLOGIES LTD (CH) | 2008-09-02 | — | — | US | claimed |
| EP-1385914-B1 | DICHROIC MIXTURE | ROLIC AG (CH) | 2008-07-23 | — | — | EP | claimed |
| EP-1617814-B1 | METHOD FOR THE DISPERSION OF WATER-SOLUBLE OR HYDROPHILIC SUBSTANCES IN A SUPERCRITICALLY PRESSURIZED FLUID | ETHYPHARM SA (FR) | 2008-05-28 | — | — | EP | claimed |
| EP-1256602-A1 | Dichroic mixture | Rolic AG (CH) | 2002-11-13 | — | — | EP | claimed |
| US-6252245-B1 | THIN FILM TRANSISTORS WITH DIIMIDE GROUPS | BELL NORTHERN RESEARCH, LLC | 2001-06-26 | — | — | US | claimed |
| EP-1041653-A2 | Device comprising organic N-channel semiconductor material | LUCENT TECHNOLOGIES INC. (US) | 2000-10-04 | — | — | EP | claimed |
| WO-1999033790-A1 | INSECTICIDAL FLUORO-SUBSTITUTED BENZOYLUREAS | NIHON BAYER AGROCHEM K.K. (DE) | 1999-07-08 | — | — | WO | claimed |
| US-4945139-A | SOLVENT RESISTANCE, POLYPHOSPHAZINES | ETHYL CORPORATION (US) | 1990-07-31 | — | — | US | claimed |
| EP-0003663-A2 | Amino-substituted phenyl and heteroaryl compounds, process for their preparation and pharmaceutical compositions containing them | AMERICAN CYANAMID COMPANY (US) | 1979-08-22 | — | — | EP | claimed |
| US-3996226-A | METHOLATED MELAMINES | NOBEL HOECHST CHIMIE (FR) | 1976-12-07 | — | — | US | claimed |
| WO-2024135958-A1 | LAMINATED FILM FOR SOLAR MODULE HAVING EXCELLENT RADIATION COOLING PROPERTIES, AND SOLAR MODULE COMPRISING SAME | 이근수 | 2024-06-27 | — | — | WO | disclosed |
| US-3996226-A | METHOLATED MELAMINES | NOBEL HOECHST CHIMIE (FR) | 1976-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090191135-A1 | METHODS FOR THE DISPERSION OF WATER-SOLUABLE OR HYDROPHILIC SUBSTANCES IN A SUPERCRITICALLY PRESSURIZED FLUID | AQP1, AQP3, AQP4 | LMNA 2636/4885THRB 3246/4885CA2 102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.